Products found to contain undeclared medicines
|
| |
| The United States: Public Notification: Body Shape Weight Loss System contains hidden drug ingredients |
| |
The United States Food and Drug Administration (FDA) continues to advise consumers not to purchase or use Body Shape Weight Loss System, a product promoted and sold for weight loss. This product was identified during an examination of international mail shipments.
FDA laboratory analysis confirmed that Body Shape Weight Loss System contains sibutramine and phenolphthalein not listed on the product label.
Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. This product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or heart rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.
Phenolphthalein is a chemical that is not an active ingredient in any approved drug in the United States. Studies have indicated that it may increase the risk of cancer.
Please refer to the following website in FDA for details:
http://www.fda.gov/drugs/medication-health-fraud/public-notification-body-shape-weight-loss-system-contains-hidden-drug-ingredients
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by FDA, and was posted on the Drug Office website on 4 Jul 2018 and 25 Nov 2020.
Ends/Thursday, Oct 3, 2024
Issued at HKT 14:45
|
| |
|
